SCHEMBL1967758

SCHEMBL1967758

CS(=O)(=O)c1cc(C(N)=O)ccc1-n1c(Nc2c(Cl)cccc2Cl)nc2cc(C(=O)O)ccc21

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.45
HSD17B10 Q99714 1/20 0.39
KIF11 P52732 4/20 0.39
CYP2C9 P11712 1/20 0.39
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
MTOR P42345 1/20 0.37
PIK3CG P48736 1/20 0.37
THRB P10828 1/20 0.37
RORC P51449 2/20 0.37
PDE4B Q07343 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
IDH1 O75874 2/20 0.36
STING1 Q86WV6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1967011 0.85 LCK (0.45) LCKHSD17B10CSNK2A2CSNK2BCSNK2A1
SCHEMBL1964624 0.85 LCK (0.45) LCKHSD17B10CYP2C9CSNK2A2CSNK2B
SCHEMBL1965650 0.83 LCK (0.43) LCKHSD17B10CSNK2A2CSNK2BCSNK2A1
SCHEMBL1973510 0.81 HSD17B10 (0.44) LCKHSD17B10CSNK2A2CSNK2BCSNK2A1
SCHEMBL1967636 0.81 LCK (0.46) LCKHSD17B10CSNK2A2CSNK2BCSNK2A1
SCHEMBL1964840 0.80 LCK (0.47) LCKHSD17B10CSNK2A2CSNK2BCSNK2A1
SCHEMBL1966409 0.80 LCK (0.42) LCKHSD17B10CSNK2A2CSNK2BCSNK2A1
SCHEMBL1968408 0.79 LCK (0.42) LCKKIF11CYP2C9PIK3CDPIK3CA
SCHEMBL1969959 0.78 LCK (0.47) LCKKIF11CYP2C9PIK3CDPIK3CA
SCHEMBL1967727 0.77 LCK (0.56) LCKHSD17B10CSNK2A2CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334652-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2011-06-22 EP claimed